USNU (US Neurosurgical Holding) Research & Development : $0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is US Neurosurgical Holding Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. US Neurosurgical Holding's Research & Development for the three months ended in Sep. 2024 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0.00 Mil.

US Neurosurgical Holding Research & Development Historical Data

The historical data trend for US Neurosurgical Holding's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

US Neurosurgical Holding Research & Development Chart

US Neurosurgical Holding Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Research & Development

Get a 7-Day Free Trial

US Neurosurgical Holding Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Research & Development	Get a 7-Day Free Trial															-	-	-	-	-

US Neurosurgical Holding Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

US Neurosurgical Holding (OTCPK:USNU) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

US Neurosurgical Holding Research & Development Related Terms

Thank you for viewing the detailed overview of US Neurosurgical Holding's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

US Neurosurgical Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » US Neurosurgical Holding Inc (OTCPK:USNU) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

N/A

Address

1131 W 6th Street, Ontario, CA, USA, 91672

Website

http://www.usneuro.com

US Neurosurgical Holding Inc operates as a holding company in the United States. It is a medical services company that partners with hospitals and physicians to operate facilities utilizing artistic and inventive technologies in medical treatment and diagnosis. It is engaged in providing medical treatment and diagnosis services that include stereotactic radiosurgery centers, utilizing gamma knife technology, and holds interests in radiological treatment facilities. The company is focusing on establishing cancer centers using intensity-modulated radiation therapy. Its gamma knife is a stereotactic radiosurgical device used to treat brain tumors and other malformations of the brain without invasive surgery.

Executives

Lawrence William St	director	23 ASHLAND STREET, NEWBURYPORT MA 01950-1905
William F. Leimkuhler	director	43 SALEM STRAITS RD, DARIEN CT 06820
Merriman Charles H Iii	director
Alan Gold	director, 10 percent owner, officer: President & Chairman	2400 RESEARCH BLVD, SUITE 325, ROCKVILLE MD 20850
Stanley S Shuman	10 percent owner	C/O RIPPLEWOOD HOLDINGS LLC, ONE ROCKERFELLER PLAZA, NEW YORK NY 10020
Allen & Co Inc	10 percent owner	711 FIFTH AVENUE, NEW YORK NY 10022